CEPHEID (CPHD)
CEPHEID Key Statistics
Pro Data ExportCurrent Valuation
Dividends and Shares
| Dividend | |
| Dividend Yield | 0.00% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Dividend Date | |
| Ex-Dividend Date | |
| Last Split Factor | |
| Last Split Date |
Profitability
| Gross Profit Margin | 53.93% |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
| Profit Margin | -7.15% |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 3.061 |
| Debt to Equity Ratio | 0.00 |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | -0.08% |
| Year to Date Stock Returns | 11.80% |
| 1 Year Stock Returns | 20.11% |
| 3 Year Stock Returns | 278.6% |
| 52 Week High | 45.00 |
| 52 Week Low | 29.71 |
Income Statement
| Revenues TTM | 294.65M |
| Revenue Per Share TTM | 4.500 |
| Revenue Growth | 28.35% |
| Gross Profit TTM | 161.51M |
| EBITDA TTM Pro | Go Pro |
| Income from Cont. Ops Pro | Go Pro |
| Net Income TTM | -3.426M |
| Earnings Per Share TTM | -0.05 |
| Other Comprehensive Income Pro | Go Pro |
Cash Flow Statement
| Cash Investing TTM | -37.63M |
| Cash Financing TTM | 40.23M |
| Cash Operations TTM | 21.50M |
| Capital Expenditures | 4.587M |
Share Statistics
| Shares Outstanding | 65.47M |
Balance Sheet
| Cash and ST Investments | 103.99M |
| Total Assets | 308.68M |
| Liabilities | 77.19M |
| Book Value | 231.48M |
| Book Value per Share | 3.536 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
| Long Term Debt | 0.00 |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
You may also be interested in these CPHD related companies
CPHD News
$CPHD Target $50 based on new results Artcile link http://stks.co/3yVV May 24
about 4 days ago by Jack25bc
about 4 days ago by Jack25bc
Canaccord Genuity Reiterates a 'Buy' on Cepheid (CPHD); Rolling Out Another Assay
May 24, 8:45AM Street Insider
May 24, 8:45AM Street Insider
$CPHD a new lows, but volume lower than last week, and probably sellers fading away, a possible entry if it holds 52.88 area.
about 8 days ago by woowtrading
about 8 days ago by woowtrading
UPDATE: UBS Investment Research Upgrades Cepheid to Buy; Opportunistic Inflection
May 15, 11:04AM Benzinga
May 15, 11:04AM Benzinga
UPDATE: GARP Research & Securities Downgrades Cepheid to Neutral; Valuation Full
May 14, 11:29AM Benzinga
May 14, 11:29AM Benzinga
GARP Research Downgrades Cepheid (CPHD) to Neutral; Walking A Thin Line
May 14, 10:08AM Street Insider
May 14, 10:08AM Street Insider
Listen to $CPHD Cepheid at Deutsche Bank AG Health Care Conference - live at 10:00 AM, ondemand after - http://stks.co/3k3V
about 19 days ago by earningscast
about 19 days ago by earningscast
$CPHD http://stks.co/3aR0 If it breaks todays lod tomorrow.... will short it.
about 28 days ago by Bav111
about 28 days ago by Bav111
GARP Research Of In Defense on Cepheid (CPHD); Franchise Remains Solid Plus Progress In Pipeline
Apr 25, 12:57PM Street Insider
Apr 25, 12:57PM Street Insider
UBS Maintains a 'Neutral' on Cepheid (CPHD); Solid Top-Line Eclipsed by Below-Consensus EPS
Apr 20, 12:56PM Street Insider
Apr 20, 12:56PM Street Insider
Canaccord Genuity Reiterates a 'Buy' on Cepheid (CPHD); Pick Up Shares on Weakness
Apr 20, 8:51AM Street Insider
Apr 20, 8:51AM Street Insider
$CPHD's John Bishop wins the no-spin award for the week. Described this quarter's bottom line as "less than satisfactory to say the least."
about 39 days ago by bradloncar
about 39 days ago by bradloncar
News related to $CPHD: 'Cepheid cuts annual outlook after taking 1Q loss' http://stks.co/3QPR
about 39 days ago by TradeBot
about 39 days ago by TradeBot
Listen to $CPHD Q1 2012 earnings call - live at 05:00 PM, ondemand after - http://stks.co/3QMv
about 39 days ago by earningscast
about 39 days ago by earningscast
Cepheid, Inc. (CPHD) Reports In-Line Q1 Loss; Guides FY12 EPS Above Views
Apr 19, 4:08PM Street Insider
Apr 19, 4:08PM Street Insider
Canaccord Genuity on Life Sciences/Biomedical Devices & Services: Pipelines To Lead Way Through Q1
Apr 18, 10:25AM Street Insider
Apr 18, 10:25AM Street Insider
News related to $CPHD: 'Quidel rises on new clearance for flu test' http://stks.co/31m2
about 67 days ago by TradeBot
about 67 days ago by TradeBot
Approaching a pivot after a few week of earnings breakout consolidation $CPHD http://chart.ly/rflpbdb
about 70 days ago by ivanhoff
about 70 days ago by ivanhoff
$CPHD http://stks.co/2uxy flagging with a trigger long over 43 to a MM at 47
about 72 days ago by harmongreg
about 72 days ago by harmongreg
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CPHD | 38.47 | +0.38 | +1.00% | 2.519B |
| DLB | 43.96 | -0.04 | -0.09% | 4.777B |
| DLA | 14.17 | -0.03 | -0.21% | 119.74M |
| DL | 3.40 | -0.07 | -2.02% | 120.60M |
| DKA | 21.58 | -0.07 | -0.32% | |
| DK | 16.91 | +0.47 | +2.86% | 983.49M |
| DCOM | 13.34 | +0.04 | +0.30% | 469.17M |
| DCM | 15.83 | -0.05 | -0.31% | 65.64B |
| DCIX | 7.07 | -0.02 | -0.28% | 163.18M |
| DCI | 36.12 | -0.15 | -0.41% | 5.379B |
